PharmaDrug Innovates in Biosynthetic Cocaine Market
Company Announcements

PharmaDrug Innovates in Biosynthetic Cocaine Market

Pharmadrug Inc. (TSE:PHRX) has released an update.

PharmaDrug Inc. is advancing its patent-pending process for producing pharmaceutical-grade biosynthetic cocaine, targeting the safe supply market. The company is gearing up for commercialization by establishing strategic partnerships and leveraging streamlined regulatory pathways to accelerate market entry. Emphasizing quality and safety, PharmaDrug aims to offer a reliable alternative to street drugs, aligning with harm reduction and rehabilitation initiatives.

For further insights into TSE:PHRX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskPharmaDrug Debenture Units Issuance Announcement
TipRanks Canadian Auto-Generated NewsdeskPharmaDrug Advances PD-001 for Clinical Trials
TipRanks Canadian Auto-Generated NewsdeskPharmaDrug Begins Clinical Trial for Infectious Disease Treatment
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App